Literature DB >> 15901868

Early use of drastic therapy.

Kenneth I Weinberg.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15901868     DOI： 10.1056/NEJMe058071

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Cellular transplant therapies for globoid cell leukodystrophy: Preclinical and clinical observations.

Authors:  Keri R Maher; Andrew M Yeager
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy.

Authors:  Adarsh S Reddy; Joong H Kim; Jacqueline A Hawkins-Salsbury; Shannon L Macauley; Elisabeth T Tracy; Carole A Vogler; Xialin Han; Sheng-Kwei Song; David F Wozniak; Stephen C Fowler; Robyn S Klein; Mark S Sands
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

3.  Disease specific therapies in leukodystrophies and leukoencephalopathies.

Authors:  Guy Helman; Keith Van Haren; Joshua L Bonkowsky; Genevieve Bernard; Amy Pizzino; Nancy Braverman; Dean Suhr; Marc C Patterson; S Ali Fatemi; Jeff Leonard; Marjo S van der Knaap; Stephen A Back; Stephen Damiani; Steven A Goldman; Asako Takanohashi; Magdalena Petryniak; David Rowitch; Albee Messing; Lawrence Wrabetz; Raphael Schiffmann; Florian Eichler; Maria L Escolar; Adeline Vanderver
Journal:  Mol Genet Metab       Date:  2015-02-07       Impact factor: 4.797

4.  Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy.

Authors:  Elizabeth Y Qin; Jacqueline A Hawkins-Salsbury; Xuntian Jiang; Adarsh S Reddy; Nuri B Farber; Daniel S Ory; Mark S Sands
Journal:  Mol Genet Metab       Date:  2012-06-01       Impact factor: 4.797

Review 5.  Emerging treatments for pediatric leukodystrophies.

Authors:  Guy Helman; Keith Van Haren; Maria L Escolar; Adeline Vanderver
Journal:  Pediatr Clin North Am       Date:  2015-04-08       Impact factor: 3.278
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.